经皮左心耳封堵术预防非瓣膜性房颤卒中研究进展  

Percutaneous Left Atrial Appendage Occlusion for Stroke Prevention in Non-valvular Atrial Fibrillation

作　　者：周仪梦 杨浩[1] ZHOU Yimeng;YANG Hao(Department of Cardiology,Yijishan Hospital,Wannan Medical College,Wuhu 241001,China)

机构地区：[1]皖南医学院弋矶山医院心血管内科,安徽芜湖241001

出　　处：《沈阳医学院学报》2018年第3期266-271,共6页Journal of Shenyang Medical College

摘　　要：心房颤动(房颤)是临床上最常见的心律失常,血栓栓塞致脑卒中是其并发症之一。口服抗凝药是预防房颤卒中的基础治疗,但部分患者存在抗凝药物禁忌。鉴于90%的非瓣膜性房颤患者的血栓来自于左心耳,因此左心耳封堵术成为非瓣膜性房颤卒中高危患者及对抗凝药物有禁忌患者的一项治疗手段。Atrial fibrillation is one of the most common arrhythmias in clinical practice. Thromboembolism is one of the complications of atrial fibrillation,which may lead to serious stroke. Oral anticoagulant therapy is the basic treatment for stroke prevention in atrial fibrillation patients. Since 90% thrombus of patients with non- valvular atrial fibrillation are from left atrial appendage,the left atrial appendage occlusion is a treatment for patients with high risk of stroke and contraindication to anticoagulant .

关 键 词：房颤 左心耳 血栓栓塞 封堵术 抗凝疗法 禁忌证 

分 类 号：R541.75[医药卫生—心血管疾病]